Mustang Bio (MBIO) Current Assets (2016 - 2025)
Mustang Bio (MBIO) posted quarterly Current Assets of $17.6 million for Q4 2025, up 104.43% year-over-year from $8.6 million in Q4 2024, and down 9.13% quarter-over-quarter from $19.4 million in Q3 2025.
Mustang Bio (MBIO) Current Assets (2016 - 2025) Analysis & Trends
Mustang Bio (MBIO) has reported Current Assets for 10 consecutive years, with $17.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Assets rose 104.43% year-over-year to $17.6 million; the TTM figure through Dec 2025 stood at $17.6 million (up 104.43% YoY), while the FY2025 annual figure was $17.6 million, up 104.43% from the prior year.
- Current Assets slipped to $17.6 million in Q4 2025 per MBIO's latest filing, from $19.4 million in the prior quarter.
- Across five years, Current Assets topped out at $131.3 million in Q2 2021 and bottomed at $6.1 million in Q3 2024.
- Historically, Current Assets has averaged $55.4 million across 5 years, with a median of $21.0 million in 2023.
- Annual changes were most pronounced in 2023 — Current Assets slumped 85.61% — and 2025, when it jumped 219.75%.
- Mustang Bio's Current Assets stood at $111.7 million in 2021, then dropped by 29.41% to $78.9 million in 2022, then tumbled by 85.61% to $11.3 million in 2023, then retreated by 24.15% to $8.6 million in 2024, then soared by 104.43% to $17.6 million in 2025.
- Business Quant data shows MBIO's Current Assets at $17.6 million in Q4 2025, $19.4 million in Q3 2025, and $13.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - | 1.76 Bn |
| 10 | Mustang Bio | 3.84 Mn | 3.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.59 Mn |
| Sep 30, 2025 | 19.36 Mn |
| Jun 30, 2025 | 13.05 Mn |
| Mar 31, 2025 | 14.91 Mn |
| Dec 31, 2024 | 8.61 Mn |
| Sep 30, 2024 | 6.06 Mn |
| Jun 30, 2024 | 7.32 Mn |
| Mar 31, 2024 | 9.24 Mn |
| Dec 31, 2023 | 11.35 Mn |
| Sep 30, 2023 | 13.59 Mn |
| Jun 30, 2023 | 22.58 Mn |
| Mar 31, 2023 | 61.13 Mn |
| Dec 31, 2022 | 78.85 Mn |
| Sep 30, 2022 | 94.45 Mn |
| Jun 30, 2022 | 109.38 Mn |
| Mar 31, 2022 | 124.15 Mn |
| Dec 31, 2021 | 111.71 Mn |
| Sep 30, 2021 | 121.95 Mn |
| Jun 30, 2021 | 131.34 Mn |
| Mar 31, 2021 | 130.97 Mn |